Nevro Initiated With Buy Rating At Bank Of America

Loading...
Loading...

Bank of America Merrill Lynch has started coverage of Nevro Corp NVRO with a Buy rating and price objective of $100, implying a potential return of 24 percent.

Nevro's Senza Spinal Cord Stimulation (SCS) system delivers HF10 (high frequency) therapy to treat patients suffering from chronic pain.

"In a field where clinical data are limited, NVRO has generated Level 1 clinical data supporting the efficacy of the Senza system in treating both back pain and leg pain and is considered to be a technological breakthrough in the spinal cord stimulation field," analyst Bob Hopkins wrote in a note.

No wonder, the FDA approved the Senza system in May 2015 and gave the Senza system a superiority label over traditional spinal cord stimulation devices and paresthesia-free indication.

"In our view, the Senza system is technologically superior to the competition, eliminates the pins-and-needles feeling of competitive devices, has gained a 'superiority' label from FDA, and is easier to implant than competitive devices," Hopkins continued.

The analyst said Nevro targets the $1.6 billion pain stimulation market, which he forecast to be a 10 percent growth market that could ultimately be $3 billion–$4 billion size.

Related Link: Piper Jaffray Initiates Coverage On Nevro At Overweight

"Our 2020 NVRO model assumes ~25 percent market share and a $2.5b market, but we see upside to both our market share and market size estimates. On our estimates, 2020 earnings power could be in the $2.50–3.00 range," Hopkins elaborated.

For 2016, the analyst expects EPS of ($1.73) and revenue of $205 million.

Nevro is reporting its second-quarter results on Monday after the market. Street expects a loss of $0.47 and revenue of $45.11 million.

At the time of writing, shares of Nevro were up 0.83 percent to $81.22.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorLong IdeasPrice TargetInitiationAnalyst RatingsTrading IdeasBob HopkinsBofA Merrill Lynch
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...